OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
5.12
+0.22 (4.49%)
At close: Jun 26, 2026, 4:00 PM EDT
5.12
0.00 (0.00%)
Pre-market: Jun 29, 2026, 7:07 AM EDT
OptimizeRx Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for OptimizeRx stock have an average target of 12, with a low estimate of 7.00 and a high estimate of 18. The average target predicts an increase of 134.38% from the current stock price of 5.12.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 13, 2026.
Analyst Ratings
The average analyst rating for OptimizeRx stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B. Riley Securities | B. Riley Securities | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +95.31% | May 13, 2026 |
| Stephens | Stephens | Hold Reiterates $7 | Hold | Reiterates | $7 | +36.72% | May 13, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $17 → $14 | Buy | Reiterates | $17 → $14 | +173.44% | May 13, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | May 13, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $18 | Buy | Reiterates | $18 | +251.56% | May 13, 2026 |
Financial Forecast
Revenue This Year
97.41M
from 109.43M
Decreased by -10.98%
Revenue Next Year
108.89M
from 97.41M
Increased by 11.79%
EPS This Year
0.94
from 1.05
Decreased by -10.67%
EPS Next Year
1.09
from 0.94
Increased by 16.42%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 98.6M | 118.9M | |
| Avg | 97.4M | 108.9M | |
| Low | 95.0M | 103.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -9.9% | 22.1% | |
| Avg | -11.0% | 11.8% | |
| Low | -13.2% | 6.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.00 | 1.29 | |
| Avg | 0.94 | 1.09 | |
| Low | 0.88 | 0.94 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -4.8% | 37.5% | |
| Avg | -10.7% | 16.4% | |
| Low | -16.2% | 0.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.